Inventor · disambiguated record
David Fitzpatrick
Also filed as: FITZPATRICK DAVID · FITZPATRICK DAVID R · FITZPATRICK DAVID RONALD
12 granted patents·10 pending applications·189 citations·filing 1988–2023
92Inventor score
Top patents by PatentIndex Score
22 records- 0197US7833527B2Methods of treating psoriasis using IL-17 Receptor A antibodiesAMGEN INC·Filed 2007·Granted Nov 16, 2010·57 cites·22 claims
- 0296US8790648B2Methods of treating psoriasis using IL-17 receptor A antibodiesTOCKER JOEL·Filed 2012·Granted Jul 29, 2014·27 cites·59 claims
- 0394US8435518B2Methods of using IL-17 receptor a antibodiesTOCKER JOEL·Filed 2010·Granted May 7, 2013·23 cites·65 claims
- 0489US2024294652A1Il-17 receptor a antigen binding proteinsAMGEN K A INC·Filed 2023·Application pending·0 cites
- 0588US10208122B2IL-17 receptor A antigen binding proteinsAMGEN K A INC·Filed 2016·Granted Feb 19, 2019·4 cites·5 claims
- 0678US7917427B2Method and system for providing rule-based collateral allocation and substitutionICAP SERVICES NORTH AMERICA LLC·Filed 2009·Granted Mar 29, 2011·8 cites·3 claims
- 0775US11858999B2IL-17 receptor A antigen binding proteinsAMGEN K A INC·Filed 2020·Granted Jan 2, 2024·0 cites·4 claims
- 0875US5151267ABovine herpesvirus type 1 polypeptides and vaccinesUNIV SASKATCHEWAN·Filed 1988·Granted Sep 29, 1992·51 cites·17 claims
- 0973US11180564B2IL-17 Receptor A antigen binding proteinsAMGEN K A INC·Filed 2018·Granted Nov 23, 2021·0 cites·3 claims
- 1068US2014356355A1Il-17 receptor a antigen binding proteinsAMGEN INC·Filed 2014·Application pending·0 cites
- 1167US2010028345A1Il-17 receptor a antigen binding proteinsAMGEN INC·Filed 2007·Application pending·0 cites
- 1264US7593886B2Method and system for providing rule-based collateral allocation and substitutionICAP SERVICES NORTH AMERICA LL·Filed 2003·Granted Sep 22, 2009·1 cites·9 claims
- 1361US2019203209A1Method of Modulating Fibroblast Accumulation or Collagen DepositionAMGEN INC·Filed 2019·Application pending·0 cites
- 1457US2006171943A1Compositions and methods of treating fibrotic disordersAMGEN INC·Filed 2006·Application pending·0 cites
- 1554US2017081668A1Method of Modulating Fibroblast Accumulation or Collagen DepositionAMGEN INC·Filed 2016·Application pending·0 cites
- 1653US2011117053A1Method of modulating fibroblast accumulation or collagen depositionAMGEN INC·Filed 2011·Application pending·0 cites
- 1748US2003027334A1Method for generating immortal dendritic cell linesFiled 2002·Application pending·0 cites
- 1845US5585264ANucleotide sequences encoding recombinant bovine herpesvirus type-1 GI, GIII and GIV polypeptidesUNIV SASKATCHEWAN·Filed 1992·Granted Dec 17, 1996·9 cites·72 claims
- 1943US2002132342A1Method for generating immortal dendritic cell linesFiled 2001·Application pending·0 cites
- 2042US2006039910A1Methods and compositions for treating allergic inflammationAMGEN INC·Filed 2005·Application pending·0 cites
- 2138US5879895ARecombinant bovine herpesvirus type 1 polypeptides and immunoassaysUNIV SASKATCHEWAN·Filed 1996·Granted Mar 9, 1999·4 cites·8 claims
- 2238US5858989AVaccines comprising nucleotide sequences encoding bovine herpesvirus type 1 g1, g111 and gIVUNIV SASKATCHEWAN·Filed 1996·Granted Jan 12, 1999·5 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when David Fitzpatrick files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →